In a 60-year-old woman with a seizure disorder treated with levetiracetam (Keppra), what is the appropriate management for new visual hallucinations of red, orange, and yellow colors?

Discontinue Levetiracetam Immediately - This is a Known Psychiatric Side Effect

The visual hallucinations of colors (red, orange, yellow) in this 60-year-old woman on levetiracetam (Keppra) represent a recognized psychiatric adverse effect of the medication that requires immediate discontinuation and transition to an alternative antiseizure medication.

Understanding the Problem

Levetiracetam is well-documented to cause psychiatric side effects, including hallucinations. The FDA drug label explicitly warns about "mood and behavior changes" and specifically mentions that patients can experience hallucinations 1. Multiple case reports confirm visual and auditory hallucinations as rare but serious complications of levetiracetam therapy 2, 3, 4, 5.

Key clinical features that confirm this is drug-related:

• Temporal relationship: Hallucinations typically occur within days to months of starting levetiracetam
• The visual nature (seeing specific colors) is consistent with reported cases
• Complete resolution occurs within days of discontinuing or reducing the dose 2, 3, 4, 5

Immediate Management Algorithm

Step 1: Rule Out Alternative Causes (Rapid Assessment)

Before attributing this solely to levetiracetam, quickly exclude:

• Charles Bonnet Syndrome: Does she have significant vision loss? CBS requires visual impairment plus insight that hallucinations aren't real 6. If vision is normal, this is unlikely.
• Seizure activity: Are these ictal phenomena? Brief stereotyped episodes suggest seizures; persistent colorful hallucinations throughout the day suggest medication effect.
• Metabolic derangements: Check basic labs (glucose, sodium, renal function) - but don't delay medication change for this.

Step 2: Discontinue Levetiracetam

Do not continue levetiracetam. The evidence shows dramatic improvement within days of stopping 2, 3, 4, 5. While the neuro-oncology guideline notes that levetiracetam has become "the drug of first choice" due to concerns about psychiatric side effects being "a concern" 7, when those psychiatric effects actually manifest, the drug must be stopped.

Step 3: Transition to Alternative Antiseizure Medication

Based on current guidelines, appropriate alternatives include 7:

First choice: Lamotrigine

• Good antiseizure activity with better tolerability profile
• Requires slow titration over several weeks
• Bridge with another agent if immediate seizure control needed

Second choice: Valproic acid

• Still has "a firm place" with good efficacy and tolerability 7
• Contraindication: Do NOT use if patient is of childbearing potential
• Can be loaded more rapidly than lamotrigine

Avoid: Phenytoin, phenobarbital, carbamazepine due to side-effect profiles and drug interactions 7

Step 4: Bridge Strategy During Transition

If seizure control is urgent while titrating lamotrigine:

• Consider short-term valproic acid (if not contraindicated)
• Or use lacosamide as add-on treatment 7

Expected Timeline for Resolution

Hallucinations should resolve within 2-7 days of discontinuing levetiracetam based on published case series 2, 3, 4, 5. If hallucinations persist beyond one week after stopping the medication, reassess for alternative diagnoses.

Critical Pitfalls to Avoid

1. Don't assume this is seizure-related: The persistent nature of colorful visual hallucinations throughout the day is more consistent with medication effect than ictal phenomena.

2. Don't reduce the dose and continue: While dose reduction resolved symptoms in some cases 5, complete discontinuation is safer given the severity of hallucinations and availability of effective alternatives.

3. Don't overlook pre-existing risk factors: The literature suggests patients with prior cognitive deficits or behavioral problems may be at higher risk 5, but this doesn't change management - the drug still needs to be stopped.

4. Don't delay transition: Levetiracetam guidelines note that psychiatric side effects "remain a concern" 7, and when they occur, prompt action prevents progression to more severe psychosis 4, 8.

Documentation and Follow-up

• Document this as an adverse drug reaction
• Ensure patient understands hallucinations are medication-related, not psychiatric illness
• Follow up within 3-5 days to confirm resolution
• Ensure new antiseizure medication is therapeutic before complete levetiracetam washout